Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Choo, Eun Ju, Chambers, Henry F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204005/
https://www.ncbi.nlm.nih.gov/pubmed/28032484
http://dx.doi.org/10.3947/ic.2016.48.4.267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204005/
https://www.ncbi.nlm.nih.gov/pubmed/28032484
http://dx.doi.org/10.3947/ic.2016.48.4.267

Ejemplares similares